Patent assignee · US · COMPANY

CHIMERIX, INC.

🏢 View company profile →
28Patents
24Active
28Granted
49Portfolio score

Filing activity: Mar 27, 1987 → Jan 27, 2021 · 7 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US4923819A Time-resolved fluorescence immunoassay Emerging Cross-Sectional Technologies 86 Expired
US6448392B1 Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use Chemistry; Metallurgy 75 Expired
US4855930A Method and appartatus for improved time-resolved fluorescence spectroscopy Physics 67 Expired
US7749983B2 Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates Chemistry; Metallurgy 63 Active
US6599887B2 Methods of treating viral infections using antiviral liponucleotides Chemistry; Metallurgy 44 Expired
US8569321B2 Phosphonate ester derivatives and methods of synthesis thereof Emerging Cross-Sectional Technologies 24 Active
US8962829B1 Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Chemistry; Metallurgy 23 Active
US8614200B2 Compounds, compositions and methods for treating ocular conditions Emerging Cross-Sectional Technologies 21 Active
US9006218B2 Nucleoside phosphonate salts Chemistry; Metallurgy 21 Active
US7994143B2 Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates Chemistry; Metallurgy 18 Active
US8993542B2 Methods of treating viral infections Emerging Cross-Sectional Technologies 17 Active
US9371344B2 Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Chemistry; Metallurgy 5 Active
US9303051B2 Phosphonate ester derivatives and methods of synthesis thereof Emerging Cross-Sectional Technologies 5 Active
US8642577B2 Compounds, compositions and methods for the treatment of poxvirus infections Chemistry; Metallurgy 5 Active
US9862687B2 Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Chemistry; Metallurgy 4 Active
US10112909B2 Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Chemistry; Metallurgy 3 Active
US10487061B2 Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Chemistry; Metallurgy 2 Active
US9701706B2 Pyrrolopyrimidine nucleosides and analogs thereof Human Necessities 2 Active
US9694024B2 Methods of treating retroviral infections and related dosage regimes Emerging Cross-Sectional Technologies 2 Active
US9278135B2 Methods of treating retroviral infections and related dosage regimes Emerging Cross-Sectional Technologies 2 Active
US9708359B2 Pyrrolopyrimidine nucleosides and analogs thereof Human Necessities 2 Active
US10407457B2 Pyrrolopyrimidine nucleosides and analogs thereof Human Necessities 0 Active
US10941175B2 Pyrrolopyrimidine nucleosides and analogs thereof Human Necessities 0 Active
US9765100B2 Nucleoside phosphonate salts Chemistry; Metallurgy 0 Active
US11111264B2 Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide and uses thereof Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.